WebAurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2024, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult ... WebApr 18, 2024 · Cash of $15.9 million, marketable securities of $40.4 million, digital currencies of $2.2 million and other investments of $84.9 million as of December 31, …
BitNile Holdings Reports 2024 Year-End Results - Yahoo!
WebFeb 18, 2024 · Fourth Quarter and Full-Year 2024 Highlights. For the three months ended December 31, 2024, DraftKings reported revenue of $473 million, an increase of 47% compared to $322 million during the same period in 2024. Fourth quarter 2024 revenue exceeded the guidance previously provided by the Company during its third quarter … WebSep 30, 2024 · LAS VEGAS -- (BUSINESS WIRE)-- BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“ BitNile ” or the “ Company ”), reported its … cultural facts about paraguay
BitNile Holdings Reports Second Quarter 2024 Financial Results
WebQ4 2024 Q4 2024 % change Operating revenues 6,439: 6,209: 3.7%: Net earnings 567: 658 (13.8%) Net earnings attributable to common shareholders ... Adjusted net earnings (1) Adjusted EPS is a non-GAAP ratio and it does not have any standardized meaning under IFRS. Therefore, it is unlikely to be comparable to similar measures presented by other ... WebDec 31, 2024 · Revenues. Revenues by segment for the year ended December 31, 2024 and 2024 were as follows: Total revenue increased by $28.5 million, or 120%, to $52.4 … WebFind earnings report and search by company, date and market cap. A vertical stack of three evenly spaced horizontal lines. ... Q4 2024 Earnings Quote News Estimates: 4/14 Shanghai Automation ... eastlight homes all in